246 related articles for article (PubMed ID: 9094468)
1. Skin infiltration in acute promyelocytic leukemia.
Nagao K; Kikuchi A; Kawai Y; Kizaki M; Ikeda Y; Nishikawa T
Dermatology; 1997; 194(2):168-71. PubMed ID: 9094468
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous infiltration by leukemic cells in acute promyelocytic leukemia of a child after treatment with all-trans retinoic acid.
Kishimoto S; Ishii E; Murakami Y; Takeshita M; Watanabe M; Sakai R; Miyazaki S
Pediatr Hematol Oncol; 1997; 14(2):169-75. PubMed ID: 9089745
[TBL] [Abstract][Full Text] [Related]
5. Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid.
Giralt S; O'Brien S; Weeks E; Luna M; Kantarjian H
Leuk Lymphoma; 1994 Aug; 14(5-6):453-6. PubMed ID: 7812204
[TBL] [Abstract][Full Text] [Related]
6. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
Larson RS; McCurley TL
Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
[TBL] [Abstract][Full Text] [Related]
7. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
Nagendra S; Meyerson H; Skallerud G; Rosenthal N
Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
[TBL] [Abstract][Full Text] [Related]
8. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
Lombard EH; Mansvelt EP
Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
10. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid dendritic cell leukemia in children.
Hama A; Kudo K; Itzel BV; Muramatsu H; Nishio N; Yoshida N; Takahashi Y; Yagasaki H; Ito M; Kojima S
J Pediatr Hematol Oncol; 2009 May; 31(5):339-43. PubMed ID: 19415013
[TBL] [Abstract][Full Text] [Related]
12. Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studies.
Weiss MA; Warrell RP
Cancer; 1994 Oct; 74(7):1882-6. PubMed ID: 8082094
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
14. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
15. Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.
Jurcic JG; DeBlasio T; Dumont L; Yao TJ; Scheinberg DA
Clin Cancer Res; 2000 Feb; 6(2):372-80. PubMed ID: 10690513
[TBL] [Abstract][Full Text] [Related]
16. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
[TBL] [Abstract][Full Text] [Related]
17. The combined differentiating effect of retinoic acid and vincristine on acute promyelocytic leukemia.
Leung M; Wong K
Leuk Res; 1997 Jan; 21(1):81-4. PubMed ID: 9029190
[TBL] [Abstract][Full Text] [Related]
18. Expression of retinoic acid receptor-target genes during retinoic acid therapy for acute promyelocytic leukemia.
Takitani K; Koh M; Zhu CL; Inoue A; Kuno T; Tanoue H; Miyake M; Nakagawa T; Tamai H
Leukemia; 2003 Mar; 17(3):646-8. PubMed ID: 12646960
[No Abstract] [Full Text] [Related]
19. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
